Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Jul 23;15(7):e0236018. doi: 10.1371/journal.pone.0236018

The influence of health facility-level access measures on modern contraceptive use in Kinshasa, DRC

Saleh Babazadeh 1,*, Philip Anglewicz 2, Janna M Wisniewski 1, Patrick K Kayembe 3, Julie Hernandez 1, Jane T Bertrand 1
Editor: Kannan Navaneetham4
PMCID: PMC7377448  PMID: 32701979

Abstract

Expanding access to family planning (FP) is a principal objective of global family planning efforts and has been a driving force of national family planning programs in recent years. Many country programs are working alongside with the international family planning community to expand access to modern contraceptives. However, there is a challenging need for measuring all aspects of access. Measuring access usually requires linking information from multiple sources (e.g., individual women and facilities). To assess the influence of access to family planning services on modern contraceptive use among women, we link four rounds of individual women and service delivery points survey data from PMA2020 in Kinshasa. Multilevel logistics regression on pooled data is performed to test the influence of facility-level access factors on individual-level contraceptive use. We add variables tailored from a conceptual framework to cover elements of access to family planning: administrative access, geographic or physical access, economic access or affordability, cognitive access, service quality, and psychological access. We find that the effect of community and facility-level access factors varies extensively but having fewer stocked-out facilities and more facilities with long-acting permanent methods (LAPM) increases the odds of using modern contraceptives among women in Kinshasa. Our study shows that reliable supply chain with a broad array of method mix will increase the odds of modern contraceptive use at community level among women in Kinshasa. Using to community-oriented practices and service delivery along with empowering women to make health-related decisions should become a priority of family planning programs and international stakeholders in the country.

Introduction

Background

Expanding access to family planning (FP) is a principal objective of global family planning efforts and has been a driving force of national family planning programs in recent years. Like many other countries’ programs, the Democratic Republic of Congo’s family planning program is focused on increasing contraceptive use through improving access to family planning services, and is based on the assumption that greater access will lead to increased use [1]. The DRC, with a total fertility rate of 6.3, has one of the highest fertility rates in the world. With the current population growth rate (3.1), the DRC’s population is projected to increase by 131.6 million by 2050 [2, 3]. The DRC has planned to increase the modern contraceptive prevalence rate (mCPR) to 19% by 2020 (7.8% as of 2014) [4], reach an additional 2.1 million modern contraceptive users with a range of modern contraceptive methods as part of the FP2020 Initiative, and improve access to family planning services for men and women in the public and private sectors [1].

Kinshasa, the capital of the DRC, plays a key role in accomplishing these objectives. The urban area of Kinshasa is populated by an estimated 12 million population in a 200 square mile area, which makes it the third-largest urban area in Africa after Lagos and Cairo [5, 6]. The mCPR among women of reproductive age in Kinshasa is higher than other provinces in the DRC (26.5% as of 2018) [7]. However, Kinshasa is yet considered to have a low prevalence compared to many other FP2020 focal countries in Sub-Saharan Africa [8].

At face value, the DRC’s approach to improving access as a means of increasing utilization of FP is evidence based. Studies from the 1970s through recent years that focused on the issue of access to family planning have hypothesized that greater access would increase utilization of family planning services [915]. However, despite the emphasis placed on access to family planning, there is no consensus on the definition and measurement of access [16]. Many studies have used geographic access or proximity to the service delivery point (SDP) as a proxy of access [9, 10, 1719], but access is, in fact, a more multi-faceted concept that has individual, community, policy, and facility-level elements [15, 2023].

Quantifying such a complex concept requires multiple sources of data, including population-based surveys, facility-based surveys, and routine service statistics. Few studies have measured the magnitude of the influence of the family planning supply environment and service quality on contraceptive use, mainly because of the complexity and the lack of appropriate sources of data [15]. Linking data from those sources offers greater insight into how the availability and quality of health services in individuals’ service environment can impact healthcare-seeking behavior [24]. Some studies have linked facility data from a country’s Service Provision Assessment (SPA) with individual women’s data from the Demographic and Health Survey (DHS) to test the influence of service availability and quality on contraceptive behavior [14, 25]. Other studies have tested this association at the cluster level [18, 26, 27]. However, none of these approaches are perfect. One weakness is the fact that the spatial data from the DHS are randomly displaced as a confidentiality measure and few SPA surveys include GPS coordinates. Another issue with such linkage is that DHS and SPA surveys are rarely executed at the same time and the same clusters within a country. As a result, there is typically a time and location difference between the individual data from DHS and facility data from SPA. Both shortcomings limits the inferences that can be made using SPA and DHS data [24, 28, 29].

The objectives of this analysis are to construct a comprehensive measure of access using variables from both population and service delivery points and to test the association of access to family planning to modern contraceptive use. Using both sources of data (population-based and facility-based), we aim to assess the individual and facility-level determinants of modern contraceptive use among all women of reproductive age (15–49 years old) in Kinshasa over the four rounds of PMA2020 surveys administered between 2014 and 2016. Specifically, we analyze the relative influence of conventional socio-demographic correlates of modern contraceptive use (which affect the demand for FP services) and community-level factors related to the supply environment for FP services.

In this study, we investigate the following questions:

  1. To what extent do EA-level FP supply and services impact modern contraceptive use among women in reproductive age in Kinshasa, DRC?

  2. To what degree can the variability in contraceptive use among women in reproductive age in Kinshasa be explained by differences in EA-level contextual factor variables?

  3. To what degree can the variability in contraceptive use among women in reproductive age in Kinshasa be explained by variation in other EA-level variables?

It is important to consider that the decision to utilize contraceptive services is a product of many individual, community, provider, and service level factors. Investigating these factors and their association will provide FP programs and policy makers with the necessary evidence as to the relative importance of these factors in individual women’s decision to use modern contraceptives and identify the probable barriers to obtaining FP services.

Methods

Data

This study uses four consecutive rounds of population-based and facility-based survey data collected in Kinshasa through Performance Monitoring and Accountability 2020 (PMA2020), a multi-country platform which, similar to the DHS and SPA, surveys female respondents and service delivery points (SDP) about family planning [30]. PMA2020’s SDP and population-based data are collected at the same time and in the same clusters in multiple rounds within a country. Therefore, in this study, the population and facility data are linked at the cluster level. The surveys were conducted in the same 58 enumeration areas (EA) in four annual and semi-annual rounds (rounds 2–5) between 2014 and 2016 (rounds three and four were conducted in 2015). The sample consists of a panel of 58 EA selected in four rounds of data collection. Two-stage cluster sampling was employed for the population-based survey; at the first stage of sampling, 58 enumeration areas (EA) were randomly selected from the 335 EAs within the city of Kinshasa. In the second stage, 33 households were selected within each selected EA using systematic random sampling. All women of reproductive age in each household were eligible to be interviewed.

The sampling strategy for SDPs was slightly different. At the first stage of sampling, the same 58 EAs were selected. In the second stage, the interviewers collected data from 3–6 SDPs per EA (three public and three private SDPs). The sampling approach was different for public and private SDPs. For public SDPs, the data collectors obtained a list of all public facilities, stratified by type of facility. Within each EA, the tertiary hospital that serves the EA was selected (there is only one tertiary hospital in Kinshasa). The secondary hospitals were selected if they served the selected EA, even if they were not located in that EA itself. If the EA contained primary-level public facilities (health center, health clinic, health post) that served the population in that EA, one was randomly selected.

For private facilities, resident enumerators (REs) first listed all private SDPs within each EA. Private SDPs included faith-based SDPs, pharmacies, clinics, and other unofficial providers of FP methods (such as kiosks). Three private SDPs were selected randomly from the prepared list. As a result of sampling approach, all EAs have at least three private SDPs while only some have three public SDPs. Further, some SDPs were selected for the sample in multiple rounds. However, since they are a small fraction of all SDPs (less than 8% of all SDPs), and removing them from the analysis did not meaningfully change the results, we retained the SDPs that where selected in multiple rounds.

This study received IRB approval from Tulane SPHTM (Ref #492318) and from the Kinshasa School of Public Health (2013–2014: ESP/CE/070/13; 2015–2016: ESP/CE/070b/2015; 2015–2016: ESP/CE/070c/2015). All women and SDP staff interviewed gave informed consent and the data was fully anonymized before the analysis.

Conceptual framework

For this study we quantified access to family planning using six elements: administrative access, geographic or physical access, economic access or affordability, cognitive access, service quality, and psychological access [15, 23]. These elements are shown in Fig 1. Administrative access indicates the degree to which administrative barriers are eliminated, for example, whether the facility has restricted working hours or days, restrictive policies that lead to discrimination (e.g., age or marital status restrictions), or additional requirements to serve clients (e.g., husband’s approval). Geographic access is defined as the extent to which facilities are located so that the majority of the population can reach them with a reasonable amount of time and effort. Some consider the cost that an individual incurs to reach the facility for the FP services as a component of geographic access. Cognitive access is the extent to which potential users are aware of services (such as the existence of individual FP methods) and facilities for FP methods. Psychological access measures the extent to which social or attitudinal factors constrain potential users in seeking contraceptive methods. Examples of such factors include a husband’s opposition to FP or negative attitudes or behaviors on the part of the facility staff. Economic access demonstrates the extent to which obtaining contraceptive methods is within the economic means of the client. In other words, it is the individual’s ability and readiness to pay the service provider’s fees. Finally, service quality refers to the availability of a range of methods and counseling on these methods; in addition, it encompasses the extent to which the facility has necessary commodities, trained staff, required equipment, and appropriate infrastructure for service delivery (e.g., a proper room for inserting an IUD) [15, 23].

Fig 1. The conceptual framework of access to modern contraceptive.

Fig 1

Measurement

1. Outcome variable

The binary outcome variable, modern contraceptive use, indicates whether a woman of reproductive age–regardless of marital status–reported using a modern contraceptive to delay or prevent pregnancy at the time of the survey. In this study, modern methods of contraception are oral pills, injectables, male or female condoms, intrauterine devices, male or female sterilization, and lactational amenorrhea. Women are not considered to be using a modern method if they reported not using any contraceptive method or using periodic abstinence, withdrawal, or other traditional family planning methods.

2. Key independent variables

Three groups of independent variables were tested in this analysis.

a) The first group of independent variables is a proxy for the availability of contraceptive methods and the supply environment within the SDPs. These variables were constructed as the aggregate of availability and quality of service variables at the EA level. For this analysis, we constructed 11 EA-level SDP variables to measure elements of access to FP. The constructed SDP variables are as follows: total number of SDPs that offer family planning methods, total number of methods per SDP, total number of SDPs with more than three methods in stock, total number of SDPs with more than five methods in stock, total number of days SDPs offer FP services, total number of long-acting and permanent methods (LAPM), total number of SDPs that have the capacity to insert implants, total number of SDPs that have the capacity to insert IUDs, total number of SDPs that have been stocked-out in the past three months, total number of SDPs with fees, and total number of SDPs with water and electricity.

b) The second group of independent variables measures contextual factors (“community influences”) by calculating the mean values found for individuals on specific variables to create a “community-level” variable. Previous studies indicate that for contraceptive use, women usually navigate community norms to fulfill their ideas in terms of fertility and contraceptive decision- making [31]. A growing body of literature has investigated the role of these contextual factors in women’s contraceptive use in Sub-Saharan Africa [14, 3235]. The purpose of adding this set of control variables was to test if contextual, community-level variables have an impact on modern contraceptive behavior in Kinshasa. We constructed the level of knowledge of contraceptive methods (as the mean number of methods known) in each EA, mean wealth index in each EA, mean age in each EA, mean number of children in each EA, and the proportion of women making the final decision in each EA as the community-level variables.

c) The third group of independent variables is individual-level control variables. These variables are those have been identified as determinants of modern contraceptive use in many sub-Saharan African countries: age, household wealth index, level of educational attainment, parity, marital status, exposure to media messages on family planning (television, radio, newspaper/magazine), knowledge of contraceptive methods, and desire for more children [36, 37]. Table 1 shows the definition of all three groups of variables with the dimension of access that they represent.

Table 1. Variables representing elements of access to family planning.
Variables Definition Element of FP access
EA-level SDP variables
 Number of SDPs offer FP Number of SDPs that offer FP services in each EA Geographic access
 Number of methods per EA Number of FP methods offered in each EA Service quality
 Number of SDPs > 3 methods Number of SDPs that offer at least 3 FP methods in each EA Service quality
 Number of SDPs > 5 methods Number of SDPs that offer at least 5 FP methods in each EA Service quality
 Number of days SDPs The average number of days per week, SDPs are open in each EA Administrative access
 Number of LAPM Number of LAPM methods per SDP in each EA Service quality
 Number of SDPs insert implant Number of SDPs that offer FP services in each EA Service quality
 Number of SDPs insert IUD Number of SDPs that offer FP services in each EA Service quality
 Number of SDPs stocked-out Number of SDPs that have been stocked out in the last 3 months on any method in each EA Service quality
 Number of SDPs with fees Number of SDPs that offer FP services with fees in each EA Economic access
 Number of SDPs with water and electricity Number of SDPs that offer FP services and have running water and electricity in each EA Service quality
Individual and household variables
 Age Self-reported age of respondent at time survey Socio-demographic
 Level of education Highest educational level attained Socio-demographic
 Parity Number of children given birth Socio-demographic
 Marital status Woman's marital status Socio-demographic
 Wealth index Household wealth index in quintile Socio-demographic /Economic access
 Media Exposure to FP messages Number of media exposures (radio, television and newspaper (0–3)) Cognitive access
 Desire for having more children Individual wants more children as woman Socio-demographic
 Number of methods known Number of FP methods the individual woman knows Cognitive access
 Round of PMA2020 Round of PMA2020 data collection in Kinshasa (2–5)
EA-level community variables
 Community level of FP knowledge Average number of methods known by women in each EA Cognitive access
 Community level of wealth Average wealth index in each EA Economic access
 Community level of FP decision Average percentage of women who made decision on contraceptive use on current or previous FP use Cognitive access
 Community level parity Average number of births per woman in each EA Socio-demographic

Analysis

Descriptive analysis was performed for both individual and EA-level variables on a pooled cross-section of data from the four rounds of PMA2020 in Kinshasa. We tabulated the demographic characteristics of the women in our study population for each round of data. We also assessed statistical differences in these characteristics across four rounds of PMA2020 and conducted a bivariate analysis to test the association of both individual and EA-level SDP variables with the modern contraceptive use across four rounds.

Finally, we examined whether modern contraceptive use differs significantly by particular EA-level characteristics of supply environment and other EA-level community variables controlling for individual variables. Multilevel logistic regression was used to estimate the effect of EA-level variables and individual variables in the outcome of interest. This method is chosen for two main reasons: first, PMA2020 population survey data is sampled in a hierarchical structure, which means individuals are nested within EAs. Thus, we assume that respondents who live in the same EAs may not be independent of one another. Compared with regular individual-level regression analyses that assume all individuals are independent, the multilevel modeling approach accounts for the fact that people who live in the same area may be similar in some characteristics. Second, we assume that not only are the respondents in the same EA are similar in individual characteristics, but also, they share the same supply environment for FP methods. As a result, the multilevel model is appropriate to produce information on the proportion of total variation that is explained by EA-level predictors. Random-effects models typically include a random intercept and random slopes. This analysis allows for random intercepts across EAs and assumes fixed effects of covariates across EAs. The model can be shown with two equations: one at the individual level and one at the EA level.

The following equations define the fixed-effect and random-effect components of the model:

Level 1 (individual level)

Yij=β0j+β1jXij+rij (1)

Level 2 (EA level)

β0j=γ00+γ01Zj+u0j (2)
β1j=γ10 (3)

Substitution of (2) and (3) in (1)

Yij=g00+g10Xij+g01Zj+rij+u0j

Where

i    : individual woman

j    : EA

β0j   : the mean of Yij for EA j

γ00   : the grand mean of Yij

Xij   : the predictor variable for the individual woman i in the EA j

γ10   : the effect of the predictor variable Xij across EAs

rij and u0j : random components normally distributed and independent of each other

To assess the effects of EA variability on the current use of modern contraceptives among women in Kinshasa, we use Stata’s multilevel analysis command merqlogit. Five models are fitted (presented in Box 1):

Box 1. Fitted models and variables included in models.

Models
Model 0 Model 1 Model 2 Model 3 Model 4
EA-level SDP variable Yes Yes Yes Yes
Individual-level variable Yes Yes Yes
EA-level community average variables Yes Yes
Interaction of time with EA-level variables Yes

Null model: no independent variables were included in the model. This model tests the random effect of between-cluster variability.

Model 1: The first model included only the EA-level FP service variables drawn from the SDP survey and measures the impact of EA-level supply and service environment on modern contraceptive use.

Model 2: The second model included the individual-level variables as well as EA-level FP service variables drawn from SDP to determine their combined fixed and random effects on the use of modern contraceptives.

Model 3: In the third model, we included the EA-level factors drawn from individual data in addition to other factors in Model 2. It thus assessed the influence of community factors on modern contraceptive use controlling for individual-level factors and EA-level service variables to determine their combined fixed and random effect on the use of modern contraceptives.

Model 4: This model is fitted following the primary finding that the variable representing the round of data is significantly predictive of use of modern contraceptives. This suggests that the rapidly changing supply environment may have a different influence on modern contraceptive use at different times. In the last model, we included the interaction terms between the variable for the round of data and all the EA-level variables. This model assesses the influence of community factors, EA-level service factors and individual factors alongside with the effect of time on modern contraceptive use.

A likelihood ratio test (LR test) was used to compare the goodness-of-fit of each model against the previous model. The analysis was weighted to correct for the complex survey design used by PMA2020. All statistical analyses were conducted using Stata 15.1 [38]

Results

A. Socio-demographic profile of female respondents and contraceptive use

Overall, three socio-demographic characteristics of women did not differ significantly across the four rounds: age, number children, and education (Table 2). Over four rounds, the distribution and average of the age of interviewed women did not change significantly (mean = 28). The majority of respondents in all four rounds had secondary or higher education, ranging from 79% to 89%. The proportion of women married or in a union in the sample was significantly different throughout the rounds ranging from 43.4% to 49.9%. The percentage of pregnant women in the sample was consistent over the four rounds (4.7–5.8%). Across four rounds of data, women’s mean number of live children at the time of the interview ranged from 1.7 to 1.8. While at least 40% of women had no children, almost one third had more than three live children throughout four rounds. When women were asked if they had the desire for more children, over 78% answered positively, which was relatively consistent between rounds. Respondents were also asked if they have seen or heard anything messages about FP on television or radio or read about family planning in the newspaper in the last few months. Our analysis shows that at least one third of women had never been exposed to any FP messages. However, there was a significant change in the proportion of women who received FP messages from at least one of these sources from Round 2 to Round 5. In all rounds, television was the primary source of FP messages followed by radio and magazine (results not shown). Modern contraceptive use increased significantly over the course of four rounds, with 16.9, 17.0, 20.9, and 20.9% of women of reproductive age were using a modern contraceptive method. However, modern contraceptive use among EAs varies widely from 1.5% in some EAs to 58% in others (Fig 2).

Table 2. Individual characteristics of women PMA 2020, 2014–2016, Kinshasa, DRC.

Round 2 Round 3 Round 4 Round 5 P-value*ζ
% (N = 2902) % (N = 2715) % (N = 2756) % (N = 2595)
Age 0.603
15–24 42.6 43.3 41.6 43.0
25–34 31.4 29.1 32.5 30.7
35–49 26.0 27.6 25.9 26.3
Mean age 28.0 28.0 27.9 28.1 0.768
Education <0.001
Never 1.4 2.3 3.1 2.2
Primary 9.7 17.5 21.2 18.6
Secondary 72.9 67.4 62.6 63.6
Higher 16.0 12.8 13.1 15.7
Married/in union 49.9 46.1 43.4 47.0 0.009
Married more than once 17.2 16.1 12.9 11.1 0.044
Pregnant 5.8 5.4 5.8 4.7 0.512
Number of live children 0.129
0 40.6 40.2 41.6 41.0
1–2 28.8 30.8 29.8 31.2
+3 30.7 29.0 28.7 27.9
Mean number of children 1.8 1.7 1.7 1.7 0.963
Desire for more children? 0.492
Yes 78.1 79.0 80.7 79.8
Exposed to FP messages 57.2 56.8 68.0 67.0 0.001
Modern Contraceptive Use 16.9 17.0 20.9 20.9 0.037

* Chi-square test was conducted to test the significance in the difference of categorical variables across rounds of data.

ζ Analysis of variances was conducted to test the significance in the difference of continuous variables across rounds of data (age and number of children).

Fig 2. Modern contraceptive prevalence by EA in round 2–5 of PMA2020 Kinshasa, DR.

Fig 2

B. Family planning service availability at Enumeration Area (EA) level

Analysis of EA-level access variables drawn from the SDP survey indicates that women in each EA have access to at least two SDPs that offer FP services. Table 3 presents the family planning service availability at the EA level. The mean number of modern methods offered in each EA ranged from 9.1 in Round 2 to 11.1 in Round 3. However, when we limit the SDPs to those that have at least five methods in stock in each EA, the average number is less than one SDP in all rounds. On average, there were 1.1 to 1.5 SDPs that offered more than three modern methods in each EA. Women’s access to LAPM methods in each EA varied throughout four rounds. On average, the SDPs offered 2.1 to 2.5 LAPM methods over four rounds. Women in different EAs, on average, had access to 2.1 to 2.5 SDPs that offered LAPM. However, on average there was only one (0.8–1.1) SDP with the technical capacity necessary to insert an implant and roughly one (0.8–0.9) SDP with the technical capacity needed to insert an IUD.

Table 3. Family planning service availability per EA, PMA 2020, 2014–2016, Kinshasa, DRC.

Round 2 Round 3 Round 4 Round 5
EA-level SDP variables
Mean number SDPs offer FP 2.7 2.9 2.5 1.9
Mean number method per EA 9.1 11.1 10.3 9.4
Mean number SDPs >3 methods 1.1 1.5 1.3 1.3
Mean number SDPs > 5 methods 0.6 0.8 0.7 0.7
Mean number days per week 3.5 3.8 3.6 3.3
Mean number of LAPMs* 2.1 2.5 2.1 2.4
Mean number of SDP insert implant 1.0 1.1 0.9 1.1
Mean number of SDP insert IUD 0.8 0.8 0.8 0.9
Mean number methods stocked-out 1.9 3.3 3.3 1.7
Mean number of SDP with electricity and water 1.2 0.9 0.9 1.0
EA-level community variables
Mean number of methods known per EA 5.5 6.4 6.2 6.5
Mean wealth score per EA 0.1 0.0 0.1 0.2
Mean age per EA 28.0 28.0 27.9 28.1
Mean level of education 2.0 2.0 2.0 2.0
Mean proportion of autonomy per EA 0.2 0.2 0.2 0.2
Mean parity per EA 1.8 1.7 1.7 1.7
N (EA) 58 58 58 58

*Long-acting permanent methods.

Table 4 shows results of the bivariate test of the association between modern contraceptive use and individual women’s characteristics. This analysis indicates that age, marital status, and the number of live children are significantly associated with modern contraceptive use in all four rounds. The relationship between age and modern contraceptive use was curvilinear as expected, with lower use on both ends of the age spectrum.

Table 4. Association between modern contraceptive use and individual characteristics, PMA2020, Kinshasa, DRC.

Round 2 P-value* Round 3 P-value* Round 4 P-value* Round 5 P-value*
Age <0.0001 <0.001 <0.001 0.003
15–24 12.5 14.3 15.9 16.8
25–34 21.0 23.5 27.8 26.4
35–49 18.7 14.4 20.4 21.0
Mean age <0.001 0.128 <0.001 0.044
FP non-user 27.7 27.9 27.6 27.8
FP user 29.6 28.6 29.0 29.0
Education 0.210 0.327 0.024 0.758
Never 18.0 14.3 31.3 14.4
Primary 19.1 16.7 18.0 22.0
Secondary 16.0 16.2 20.0 20.9
Higher 19.5 21.9 28.1 20.8
Married/In union <0.001 <0.001 0.021 0.140
Yes 21.5 20.3 23.6 23.4
No 12.3 14.1 18.9 18.7
Mean number of Live children <0.001 <0.001 <0.001 0.003
Non-user 1.7 1.7 1.6 1.6
User 2.6 2.2 2.2 2.1
FP decision <0.001 <0.001 <0.001 <0.001
Individually 39.9 34.2 35.8 42.4
Others involved 12.1 13.0 16.9 15.4
Desire for additional children? <0.001 0.019 <0.001 0.001
Yes 15.1 16.0 19.4 19.0
No 23.3 20.8 27.3 28.3
Received FP ad 0.002 .008 0.011 0.005
Yes 13.5 13.5 16.3 16.4
No 19.4 19.6 23.1 23.1
N 2902 2715 2756 2595

*Based on t-test and chi-square test. Bivariate analysis of modern contraceptive use and individual women characteristics.

Multivariate multilevel analysis

We used multilevel multivariate logistic regression models to test the association between modern contraceptive use and three groups of determinants, EA-level SDP variables, community-level factors, and individual-level women’s characteristics. In Model 1, we examined the association between modern contraceptive use to EA-level SDP variables. The strength of the association between the explanatory variables and contraceptive use was measured using the odds ratio (Table 5).

Table 5. Multivariate models for modern contraceptive use, PMA2020, Kinshasa, DRC.

Model 1η Model 2ξ Model 3ψ Model 4ς
AOR SE AOR SE AOR SE AOR SE
Number of SDPs offer FP 1.04 0.05 1.09* 0.06 1.08 0.06 1.20 0.18
Number of methods per EA 1.09** 0.04 1.00 0.05 1.00 0.05 1.15 0.23
Number of SDPs > 3 methods 1.01 0.06 1.02 0.06 1.03 0.06 0.97 0.17
Number of SDPs > 5 methods 1.04 0.06 1.07 0.07 1.01 0.07 1.18 0.24
Number of days SDPs 0.92** 0.03 0.94** 0.03 0.95 0.03 0.86* 0.07
Number of SDPs with LAPM 0.97 0.04 0.99 0.05 1.00 0.05 1.28* 0.19
Number of SDPs insert implant 0.91 0.08 0.94 0.08 0.94 0.08 0.49*** 0.11
Number of SDPs insert IUD 1.04 0.09 1.03 0.10 1.05 0.10 0.81 0.23
Number of SDPs stocked-out 1.01 0.01 1.00 0.01 0.99 0.01 0.92** 0.03
Number of SDPs with fees 1.01** 0.01 1.01** 0.01 1.01 0.01 1.12 0.12
Number of SDPs with water and electricity 0.95 0.03 0.94* 0.03 0.94* 0.03 0.85** 0.06
Age
15–24 Ref. Ref. Ref.
25–34 1.54*** 0.13 1.55*** 0.14 1.57*** 0.14
35–49 1.19 0.2 1.17 0.2 1.16 0.2
Level of education
No education Ref. Ref. Ref.
Primary school 0.95 0.17 0.92 0.17 0.96 0.18
Middle secondary 1.04 0.18 1.00 0.18 1.06 0.19
Advanced secondary+ 1.39* 0.27 1.35 0.26 1.42 0.28
Marital status
Married Ref. Ref. Ref.
Never married 1.45** 0.21 1.45** 0.21 1.50** 0.22
Sep/div/wid 0.79* 0.11 0.8* 0.11 0.82 0.11
Household wealth
Quantile 1 (lowest) Ref. Ref. Ref.
Quantile 2 0.93 0.08 0.93 0.08 0.93 0.09
Quantile 3 0.95 0.09 0.97 0.09 0.97 0.09
Quantile 4 0.91 0.09 0.94 0.10 0.92 0.09
Quantile 5 0.83* 0.09 0.87 0.09 0.85 0.09
Number of FP methods known 1.08*** 0.01 1.07*** 0.01 1.07*** 0.01
Sexually active (binary) 3.84*** 0.25 3.8*** 0.24 3.78*** 0.24
Desire for more children (binary) 0.77*** 0.06 0.77*** 0.06 0.76*** 0.06
Parity 1.27*** 0.03 1.27*** 0.03 1.27*** 0.03
Number of FP message received
0 Ref. Ref. Ref.
1 1.32*** 0.09 1.31*** 0.09 1.29*** 0.09
2 1.4*** 0.1 1.34*** 0.1 1.33*** 0.1
3 1.57*** 0.19 1.53*** 0.18 1.55*** 0.19
Round of PMA2020
2 Ref. Ref. Ref.
3 0.91 0.07 0.73*** 0.07 4.5 13.68
4 1.15* 0.09 0.93 0.08 0.07 0.18
5 1.18* 0.11 0.95 0.1 0.73 1.95
EA-level number of FP methods known 1.21*** 0.06 1 0.18
EA-level wealth 0.95 0.04 1.02 0.09
EA-level age 1.01 0.03 0.99 0.06
EA-level final decision on FP 6.06*** 1.82 5.32** 3.28
EA-level parity 0.92 0.12 1.05 0.28
N 10882 10882 10882 10882
LR chi2 26.77** 104.42*** 65.92*** 82.33**

* Significant at *p ≤ 0.10;

**p ≤0.05;

***p ≤ 0.01. AOR: adjusted odds ratio, SE: standard error, LAPM: long-acting permanent method.

η Controlled for EA-level SDP variables.

ξ Controlled for EA-level SDP variables and individual-level women’s characteristics.

ψ Controlled for EA-level SDP variables, individual women’s characteristics, and EA-level community variables.

ς Controlled EA-level SDP variables, individual women’s characteristics, EA-level community variables, the interaction of time (round) and EA-level SDP variables.

Multivariate analysis of modern contraceptive use and EA-level SDP variables (Model 1) identified two factors that significantly increased the odds of contraceptive use among women in Kinshasa. Women who lived in EAs with a higher number of methods offered and a higher number of SDPs with fees had higher odds of using modern contraceptives. In contrast to the bivariate analysis results, a higher number of days per week that an SDP offered FP services decreased the predicted odds of modern contraceptive use.

In Model 2, we tested the impact of EA-level SDP variables on modern contraceptive use after controlling for individual-level women’s background characteristics. Three EA-level variables and seven of individual characteristics emerged as correlates of modern contraceptive use. After controls for women’s background characteristics, we found that in addition to number of SDPs with fees per EA (which was significantly associated to modern contraceptive use in Model 1), the number of SDPs that offer FP emerged as a positively associated variable to modern contraceptive use. Adding individual characteristics also yielded significant predictors of modern contraceptive use: being divorced or widowed, desire for more children, and being interviewed in Round 3 were negatively and significantly associated with modern contraceptive use. Furthermore, knowing a higher number of methods, being sexually active in the last 30 days, having a greater number of children, having secondary or advanced education, and being exposed to a higher number of FP messages through different media outlets were positive predictors of modern contraceptive use. Therefore, keeping all other variables constant, on average if a woman knows one more FP method, she has seven percentage points higher odds of using a modern contraceptive. In addition, women who have been sexually active have 34 percentage points higher odds of using modern contraceptives. Another finding in this model was that women with secondary and higher education had significantly higher odds of using modern contraceptives by approximately 40 percentage points. The analysis of marital status showed that women who have never been married have 45 percentage point higher, and women who are divorced or separated have 20 percentage points lower odds of using any modern contraceptives. Also, women who were exposed to FP messages via a higher number of media outlets (radio, television, and newspaper) showed an increased predicted odds of modern contraceptive use by more than 30%. Another finding in this model was the significant association of the time variable (round of PMA2020) in Rounds 4 and 5 with contraceptive use. This finding means that women in Round 4 and 5 had at least 15% higher odds of using modern contraceptives after controlling for individual background and EA-level SDP service factors.

In Model 3, shown in Table 5, we included EA-level community variables as well as EA-level SDP variables and individual-level characteristics of women. We found that two community-level variables were associated with modern contraceptive use. Women who lived in EAs with a higher average number of known FP methods had 21% higher odds of using modern contraceptive methods. Furthermore, living in EAs in which a higher proportion of women make the contraceptive decision was positively associated with modern contraceptive use; women in these EAs had at least six times higher odds of using modern contraceptives.

Model 4 controlled for individual variables, EA-level SDP and community variables and time interactions with EA-level SDP variables. This analysis suggested that of 11 EA-level SDP variables, two were significantly and positively associated with higher odds of modern contraceptive use. Women who resided in EAs with a higher number of LAPM methods offered had 28% higher odds of using a modern contraceptive. Similarly, women who lived in EAs with a greater number of stocked-out SDPs had 8% lower odds of using modern FP methods.

In the final model (Model 4), in which we simultaneously test the effects of three categories of variables on modern contraceptive use after controlling for the interaction of time variable (round) and the EA-level SDP variables, several EA-level SDP and community variables emerged as significant. Individual women who reside in EAs with higher number of SDPs that provide LAPM methods had higher odds of using modern contraceptive methods. Similarly, women who lived in EAs with higher number of stocked-out SDPs had smaller odds of using modern contraceptive methods. We also found the proportion of women within an EA who make the contraceptive decision to be positively related to use.

The significance for the EA-level SDP and time variable (round) interactions in some rounds indicated that the variation in modern contraceptive use due to EA-level variables was partly related to changes in those variables over the four rounds of the survey.

Discussion

Increasing the mCPR in a country with a fertility rate as high as that in the DRC requires a better understanding of the dynamics of modern contraceptive use and factors affecting women’s contraceptive behavior. In this study, we assessed the extent to which the FP supply environment in Kinshasa affects modern contraceptive use, taking advantage of the PMA2020 surveys with four rounds of data from both women and facilities. Considering that there is a dearth of literature on community level and supply environment factors influencing contraceptive use in the DRC, the findings from this study could inform the national family planning program and other family planning stakeholders to address the supply need for contraception, community-based interventions, and the individual needs of women in order to impact their attitudes towards contraceptive use.

To determine whether EA-level SDP variables impact modern contraceptive use among women, we introduced the individual-level women’s characteristics in addition to EA-level SDP variables. The variables that remained significantly associated with modern contraceptive use after controlling for women’s characteristics was the number of SDPs with fees per EA (Model 2). Our analysis also indicated that among individual characteristics, having secondary or higher education, number of known FP methods, and exposure to FP messages via media were significantly associated with higher modern contraceptive use among women in reproductive age. These findings were in line with several studies that reported that education has a substantial positive impact on modern contraceptive use [3941]. In many African countries, education is a predictor of socioeconomic status, as well as contraceptive use [42]. Therefore, women with lower educational attainments have lower uptake rates of contraceptives [4345]. Surprisingly, our findings did not confirm the role of wealth on modern contraceptive use. This finding is in contrast with previous results of studies from other countries [14, 45, 46], but consistent with another study from the DRC [47].

We also added the EA-level community average variables to our model. The variables that were significantly associated with modern contraceptive use were the community average of knowledge of FP methods and FP final decision. this analysis identified several aspects of community context that related to modern contraceptive use: knowledge and decision-making and exposure to FP messages. Our finding showed that women who reside in EAs that had a higher proportion of women who make decisions regarding contraception have more than five times greater odds to use modern contraceptives. This finding is consistent with the results the result of Stephenson and his colleagues’ study in Eastern Cape, South Africa [48]. The extent to which women make contraceptive decisions can indicate the level at which women in a society are empowered. Other studies also have found that female empowerment expands women’s choices and ability to make decisions, including reproductive health decisions, and it also leads to improved health-seeking behavior such as modern contraceptive use [14]. Although many studies have investigated the role of women’s empowerment in the decision-making process [49], they assessed other aspects of the decision-making such as the decision to seek health care, household decisions, financial decisions in addition to reproductive decision [5052]. Our analysis found a positive association between community-level contraceptive decision and modern contraceptive use; however, we did not have the means to further investigate the women’s empowerment more deeply.

Likewise, regarding the knowledge of contraceptives at the community level and exposure to FP messages, our findings are consistent with other previous results that found that exposure to mass media has substantial effects on attitudes towards family planning use among women [5356]. Also, another previous finding suggests that modern contraceptive use is higher when the demand is generated for FP, and women are exposed to the FP messages [57]. Our finding further supports the conventional idea that women’s use of modern contraceptive methods increases with the increase in parity [5860]. Also, we found that sexually active and single women have higher odds of using modern contraceptives compared to married women. This finding corroborates results from other studies that found that sexually active single women in Africa have greater likelihood of using contraceptives compared to married women [61, 62].

We finally introduced the interaction of the time variable (round of data) with the EA-level SDP variables as well as EA-level community average variable to the model. Inclusion of the interaction terms does not dramatically change our results. However, the final model showed that after including all three groups of variables, the mean number of SDPs with LAPM methods were significantly associated with modern contraceptive use. Also, women in EAs with higher mean number stocked-out SDPs have lower odds of modern contraceptive use. This finding indicates that among the different access measures we applied in the study, two indicators of service availability (availability of LAPM methods and having the methods in stock) influence modern contraceptive use among women. These findings align with results from Wang and colleagues who used the DHS and SPA from Kenya, Tanzania, Uganda, and Rwanda to examine the extent to which contraceptive use is associated with the regional family planning supply and service environment [14].

This analysis has multiple limitations and assumptions which stem from our data and methodology. First, this analysis is based on the assumption that official boundaries for EAs are the same as unofficial communities. Using enumeration areas as a proxy for communities is a common practice. However, we know that the enumeration areas do not equate to the actual communities. These administrative boundaries do not fully capture the socio-cultural characteristics of the population of their residents [63]. Our analysis used the predetermined EAs as an approximation to communities to link the availability of FP services to service utilization, however, we are limited because these official units do not account for social interaction criteria used in defining a neighborhood or community [64].

Second, in this analysis, we assumed that women in each EA would utilize the FP services from the same EA. Therefore, we expect any changes in supply environment in an EA to impact the modern contraceptive use in that EA. However, both qualitative and quantitative studies in the DRC and other sub-Saharan African countries have shown that women prefer to bypass the closest facility to acquire their desired method from a farther facility [6568]. This can be the product of a lack of confidence in the availability and quality of service in the closest facility [68, 69]. Also, sociocultural norms can be a powerful driver for women to bypass the closest facility to avoid encountering family and friends.

Third, the information gathered through the SDP survey is cross-sectional data and not a full picture of the ever-changing supply environment in Kinshasa. Most of the supply chain is managed by multiple donors and family planning implementing organizations which procure and distribute the commodities through parallel channels in the national health system [70]. In addition to this, the structure of service delivery in the DRC (similar to most LMICs) consists of fixed facilities, pharmacies, community-based distribution workers, unofficial drug shops, and campaign days. The SDP survey does not capture information related to the activities of organizations on campaign days, community-based distribution, and most of the unofficial drug shops.

Our findings further indicate that the applied elements of access using PMA2020 as the source of data is not necessarily sufficient to monitor FP2020 goal achievement. The FP2020 monitoring framework consists of a set of a indicators captured by some of these six elements (for example, contraceptive supply stock-out and contraceptive supply availability). Many other sources of data (service statistics, client exit interview, or administrative information) would be required to accurately capture all elements of access. Despite our effort to include all six elements of access (cognitive, psychological, economic, spatial, administrative, and service quality) from both population and SDP surveys, our variables do not completely capture women’s access in Kinshasa.

Conclusion

Using population- and facility-based data, we were able to account for the effect of the supply environment on modern contraceptive use. Having a higher number of SDPs with LAPM methods and fewer SDPs with stockouts were determinants of contraceptive use among women in Kinshasa. However, several SDP variables were not significantly associated with contraceptive use, and having more accurate information to measure access could be beneficial in determining the factors that impact modern contraceptive use.

In terms of the policy and programming implications, our findings suggest that availability of FP services with a broad array of method mix will increase the odds of modern contraceptive use among women in Kinshasa. Our results showed that having methods that are more desired among women (LAPM methods) increase women’s contraceptive use, whereas having stockout decreases their odds to use modern contraceptives. This finding emphasizes the importance of reliable availability of methods as well as the availability of the methods that women prefer.

The EA-level effects on contraceptive behavior suggest a need for family planning programming to shift focus to community-oriented practices and service delivery (for example, FP campaigns with the focus on social and behavioral change programs). Our findings also suggest that if women are involved in the contraceptive decision, they have greater odds of using modern contraceptives. We suggest that future studies include more questions regarding women’s roles in household decision-making as well as personal and health-related decisions.

Finally, the lack of significance of most of our EA-level constructed variables suggest that we lack knowledge on both sides of the supply and demand equation. We recommend that international FP stakeholders reach a consensus on the elements of access and measurement of these elements.

Acknowledgments

Dr. Patrick Kayembe passed away before the submission of the final version of this manuscript. Saleh Babazadeh accepts responsibility for the integrity and validity of the data collected and analyzed. The authors wish to acknowledge the pioneering role that Dr. Kayembe played in advancing reproductive health research in the DRC.

Data Availability

Data can be found on PMA2020 website and is available upon request at the IPUMS PMA repository at: https://pma.ipums.org/pma/index.shtml IPUMS PMA is a publicly available data that harmonizes the international family planning survey series Performance Monitoring for Action, or PMA (formerly known as Performance Monitoring and Accountability 2020 or PMA2020)

Funding Statement

BMGF is the grant awarded to Tulane University to implement PMA2020 surveys in the DRC. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Ministry of Public Health Democratic Republic of the Congo. Family Planning National Multisectoral Strategic Plan (2014–2020). 2014 2014.
  • 2.Population Reference Bureau. World Population Data Sheet 2018. 2018.
  • 3.World Bank Group. World Bank Population Estimates and Projections from 1960 to 2050 2019 [Available from: http://databank.worldbank.org/data/reports.aspx?source=2&country=COD&series=&period=.
  • 4.Ministère du Plan et Suivi de la Mise en œuvre de la Révolution de la Modernité (MPSMRM) MdlSPM, et ICF International. Enquête Démographique et de Santé en République Démocratique du Congo 2013–2014. Rockville, Maryland, USA: MPSMRM, MSP et ICF International.; 2014.
  • 5.Africopolis. 2019 [Available from: http://www.africapolis.org/explore.
  • 6.Demographia. Demographia World Urban Areas. 2019.
  • 7.PMA2020. Performance Monitoring and Accountability 2020, Kinshasa-Round 7: Key Family Planning Indicator Brief. [Kinshasa School of Public Health and Tulane School of Public Health and Tropical Medicine], Baltimore, MD: PMA2020. Bill & Melinda Gates Institute for Population and Reproductive Health, Johns Hopkins Bloomberg School of Public Health; 2018.
  • 8.FP2020. Family Planning 2020: African Prime News; 2019 [Available from: https://www.familyplanning2020.org/.
  • 9.Park CB, Cho L-J, Palmore JA. The Euiryong experiment: A Korean innovation in household contraceptive distribution. Studies in family planning. 1977;8(3):67–76. [PubMed] [Google Scholar]
  • 10.Tsui AO, Hogan DP, Teachman JD, Welti-Chanes C. Community availability of contraceptives and family limitation. Demography. 1981;18(4):615–25. [PubMed] [Google Scholar]
  • 11.Cornelius RM, Novak JA. Contraceptive availability and use in five developing countries. Studies in family planning. 1983:302–17. [PubMed] [Google Scholar]
  • 12.Hermalin AI. Fertility regulation and its costs: a critical essay. 1983. [Google Scholar]
  • 13.Chayovan N, Hermalin AI, Knodel J. Measuring accessibility to family planning services in rural Thailand. Studies in Family Planning. 1984;15(5):201–11. [PubMed] [Google Scholar]
  • 14.Wang W, Wang S, Pullum T, Ametepi P. How family planning supply and the service environment affect contraceptive use: Findings from four East African countries. 2012. [Google Scholar]
  • 15.Choi Y, Fabic MS, Adetunji J. Measuring Access to Family Planning: Conceptual Frameworks and DHS Data. Studies in Family Planning. 2016;47(2):145–61. 10.1111/j.1728-4465.2016.00059.x [DOI] [PubMed] [Google Scholar]
  • 16.RamaRao S, Jain AK. Aligning goals, intents, and performance indicators in family planning service delivery. Studies in family planning. 2015;46(1):97–104. 10.1111/j.1728-4465.2015.00017.x [DOI] [PubMed] [Google Scholar]
  • 17.Stock R. Distance and the utilization of health facilities in rural Nigeria. Social science & medicine. 1983;17(9):563–70. [DOI] [PubMed] [Google Scholar]
  • 18.Entwisle B, Rindfuss RR, Walsh SJ, Evans TP, Curran SR. Geographic information systems, spatial network analysis, and contraceptive choice. Demography. 1997;34(2):171–87. [PubMed] [Google Scholar]
  • 19.Yao J, Murray AT, Agadjanian V. A geographical perspective on access to sexual and reproductive health care for women in rural Africa. Social Science & Medicine. 2013;96:60–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Donabedian A. Aspects of medicalcare administration: Specifying requirements for health care. 1973. [Google Scholar]
  • 21.Gulliford M, Figueroa-Munoz J, Morgan M, Hughes D, Gibson B, Beech R, et al. What does' access to health care'mean? Journal of health services research & policy. 2002;7(3):186–8. [DOI] [PubMed] [Google Scholar]
  • 22.Stephenson R, Beke A, Tshibangu D. Contextual influences on contraceptive use in the Eastern Cape, South Africa. Health & place. 2008;14(4):841–52. [DOI] [PubMed] [Google Scholar]
  • 23.Bertrand JT, Hardee K, Magnani RJ, Angle MA. Access, Quality Of Care and Medical Barriers In Family Planning Programs. International Family Planning Perspectives. 1995;21(2):64–74. [Google Scholar]
  • 24.Burgert CR, Prosnitz D. Linking DHS household and SPA facility surveys: Data considerations and geospatial methods: ICF International; 2014. [Google Scholar]
  • 25.Skiles MP, Burgert CR, Curtis SL, Spencer J. Geographically linking population and facility surveys: methodological considerations. Population health metrics. 2013;11(1):1 10.1186/1478-7954-11-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ketende C, Gupta N, Bessinger R. Facility-level reproductive health interventions and contraceptive use in Uganda. International family planning perspectives. 2003:130–7. 10.1363/ifpp.29.130.03 [DOI] [PubMed] [Google Scholar]
  • 27.Chamla DD, Olu O, Wanyana J, Natseri N, Mukooyo E, Okware S, et al. Geographical information system and access to HIV testing, treatment and prevention of mother-to-child transmission in conflict affected Northern Uganda. Conflict and health. 2007;1(1):12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mensch B, Arends-Kuenning M, Jain A. The impact of the quality of family planning services on contraceptive use in Peru. Studies in family Planning. 1996:59–75. [PubMed] [Google Scholar]
  • 29.Hutchinson PL, Do M, Agha S. Measuring client satisfaction and the quality of family planning services: a comparative analysis of public and private health facilities in Tanzania, Kenya and Ghana. BMC health services research. 2011;11(1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zimmerman L, Olson H, Group PPI, Tsui A, Radloff S. PMA2020: Rapid Turn‐Around Survey Data to Monitor Family Planning Service and Practice in Ten Countries. Studies in family planning. 2017;48(3):293–303. 10.1111/sifp.12031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Colleran H, Mace R. Social network-and community-level influences on contraceptive use: evidence from rural Poland. Proceedings of the Royal Society B: Biological Sciences. 2015;282(1807):20150398 10.1098/rspb.2015.0398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kaggwa EB, Diop N, Storey JD. The Role of Individual and Community Normative Factors: A Multilevel Analysis of Contraceptive Use among Women in Union in Mali. International Family Planning Perspectives. 2008;34(2):79–88. 10.1363/ifpp.34.079.08 [DOI] [PubMed] [Google Scholar]
  • 33.Bogale B, Wondafrash M, Tilahun T, Girma E. Married women's decision making power on modern contraceptive use in urban and rural southern Ethiopia. BMC Public Health. 2011;11(1):342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dynes M, Stephenson R, Rubardt M, Bartel D. The influence of perceptions of community norms on current contraceptive use among men and women in Ethiopia and Kenya. Health & place. 2012;18(4):766–73. [DOI] [PubMed] [Google Scholar]
  • 35.Elfstrom KM, Stephenson R. The Role of Place in Shaping Contraceptive Use among Women in Africa. PLoS ONE. 2012;7(7):e40670 10.1371/journal.pone.0040670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bongaarts J, Frank O, Lesthaeghe R. The proximate determinants of fertility in sub-Saharan Africa. Population and Development Review. 1984:511–37. [Google Scholar]
  • 37.Blackstone SR, Nwaozuru U, Iwelunmor J. Factors influencing contraceptive use in sub-Saharan Africa: a systematic review. International quarterly of community health education. 2017;37(2):79–91. 10.1177/0272684X16685254 [DOI] [PubMed] [Google Scholar]
  • 38.StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC; 2017. [Google Scholar]
  • 39.Guilkey DK, Jayne S. Fertility transition in Zimbabwe: Determinants of contraceptive use and method choice. Population Studies. 1997;51(2):173–89. [Google Scholar]
  • 40.Bawah AA. Spousal communication and family planning behavior in Navrongo: a longitudinal assessment. Studies in Family Planning. 2002;33(2):185–94. 10.1111/j.1728-4465.2002.00185.x [DOI] [PubMed] [Google Scholar]
  • 41.Kradval O. Education and fertility is Sub-saharan Africa: An individual and community effect. Demography. 2002;39(2):233–50. 10.1353/dem.2002.0017 [DOI] [PubMed] [Google Scholar]
  • 42.Ejembi CL, Dahiru T, Aliyu AA. Contextual factors influencing modern contraceptive use in Nigeria. 2015. [Google Scholar]
  • 43.Ibisomi L. Is age difference between partners associated with contraceptive use among married couples in Nigeria? International Perspectives on Sexual and Reproductive Health. 2014;40(1):39–45. 10.1363/4003914 [DOI] [PubMed] [Google Scholar]
  • 44.Acharya LB. Determinants of fertility in the 1970s and 1990s in Nepal. Contribution to Nepalese Studies. 1998;25(special issues):95–108. [Google Scholar]
  • 45.Stephenson R, Tsui AO. Contextual influences on reproductive wellness in northern India. American Journal of Public Health. 2003;93(11):1820–9. 10.2105/ajph.93.11.1820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shah NM, Shah MA, Radovanovic Z. Patterns of desired fertility and contraceptive use in Kuwait. International Family Planning Perspectives. 1998;24(3):133–8. [Google Scholar]
  • 47.Akilimali P, Anglewicz P, Engale HN, Kurhenga GK, Hernandez J, Kayembe P, et al. Differences in family planning outcomes between military and general populations in Kinshasa, Democratic Republic of the Congo: a cross-sectional analysis. BMJ open. 2018;8(12):e022295 10.1136/bmjopen-2018-022295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Stephenson R, Beke A, Tshibangu D. Community and health facility influences on contraceptive method choice in the Eastern Cape, South Africa. International family planning perspectives. 2008:62–70. 10.1363/ifpp.34.062.08 [DOI] [PubMed] [Google Scholar]
  • 49.Prata N, Bell S, Fraser A, Carvalho A, Neves I, Nieto-Andrade B. Partner support for family planning and modern contraceptive use in Luanda, Angola. African journal of reproductive health. 2017;21(2):35–48. 10.29063/ajrh2017/v21i2.5 [DOI] [PubMed] [Google Scholar]
  • 50.Gage AJ. Women's socioeconomic position and contraceptive behavior in Togo. Studies in family planning. 1995:264–77. [PubMed] [Google Scholar]
  • 51.Kritz MM. The role of gender context in shaping reproductive behaviour in Nigeria. 2000. [Google Scholar]
  • 52.Kabeer N. Conflicts over credit: re-evaluating the empowerment potential of loans to women in rural Bangladesh. Microfinance: Routledge; 2009. p. 128–62. [Google Scholar]
  • 53.Cleland J, Wilson C. Demand theories of the fertility transition: An iconoclastic view. Population studies. 1987;41(1):5–30. [Google Scholar]
  • 54.Kane TT, Gueye M, Speizer I, Pacque-Margolis S, Baron D. The impact of a family planning multimedia campaign in Bamako, Mali. Studies in family planning. 1998;29(3):309–24. [PubMed] [Google Scholar]
  • 55.Jato MN, Simbakalia C, Tarasevich JM, Awasum DN, Kihinga CN, Ngirwamungu E. The impact of multimedia family planning promotion on the contraceptive behavior of women in Tanzania. International Family Planning Perspectives. 1999:60–7. [Google Scholar]
  • 56.Storey D, Boulay M, Karki Y, Heckert K, Karmacha DM. Impact of the integrated radio communication project in Nepal, 1994–1997. Journal of health communication. 1999;4(4):271–94. 10.1080/108107399126823 [DOI] [PubMed] [Google Scholar]
  • 57.Speizer IS, Corroon M, Calhoun L, Lance P, Montana L, Nanda P, et al. Demand generation activities and modern contraceptive use in urban areas of four countries: a longitudinal evaluation. Global Health: Science and Practice. 2014;2(4):410–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Curtis SL, Neitzel K. Contraceptive knowledge use and sources. 1996. [Google Scholar]
  • 59.Tuoane M, Diamond I, Madise N. Use of family planning in Lesotho: the importance of quality of care and access. African Population Studies. 2003;18(2):105–32. [Google Scholar]
  • 60.Clements S, Madise N. Who is being served least by family planning providers? A study of modern contraceptive use in Ghana, Tanzania and Zimbabwe. African journal of reproductive health. 2004:124–36. [PubMed] [Google Scholar]
  • 61.Caldwell JC, Orubuloye IO, Caldwell P. Fertility decline in Africa: A new type of transition? Population and development review. 1992:211–42. [Google Scholar]
  • 62.Adebayo SB, Gayawan E, Ujuju C, Ankomah A. Modelling geographical variations and determinants of use of modern family planning methods among women of reproductive age in Nigeria. Journal of biosocial science. 2013;45(1):57–77. 10.1017/S0021932012000326 [DOI] [PubMed] [Google Scholar]
  • 63.Engstrom R, Ofiesh C, Rain D, Jewell H, Weeks J. Defining neighborhood boundaries for urban health research in developing countries: A case study of Accra, Ghana. Journal of Maps. 2013;9(1):36–42. 10.1080/17445647.2013.765366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Pickett KE, Pearl M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. Journal of Epidemiology & Community Health. 2001;55(2):111–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Akin JS, Hutchinson P. Health-care facility choice and the phenomenon of bypassing. Health Policy and Planning. 1999;14(2):135–51. 10.1093/heapol/14.2.135 [DOI] [PubMed] [Google Scholar]
  • 66.Yao J, Agadjanian V. Bypassing health facilities in rural Mozambique: spatial, institutional, and individual determinants. BMC health services research. 2018;18(1):1006 10.1186/s12913-018-3834-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Gauthier B, Wane W. Bypassing health providers: the quest for better price and quality of health care in Chad. Social Science & Medicine. 2011;73(4):540–9. [DOI] [PubMed] [Google Scholar]
  • 68.Kante AM, Exavery A, Phillips J, Jackson E. Why women bypass front‐line health facility services in pursuit of obstetric care provided elsewhere: a case study in three rural districts of Tanzania. Tropical Medicine & International Health. 2016;21(4):504–14. [DOI] [PubMed] [Google Scholar]
  • 69.Kruk ME, Paczkowski M, Mbaruku G, De Pinho H, Galea S. Women's preferences for place of delivery in rural Tanzania: a population-based discrete choice experiment. American journal of public health. 2009;99(9):1666–72. 10.2105/AJPH.2008.146209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Kwete D, Binanga A, Mukaba T, Nemuandjare T, Mbadu MF, Kyungu M-T, et al. Family planning in the Democratic Republic of the Congo: encouraging momentum, formidable challenges. Global Health: Science and Practice. 2018;6(1):40–54. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Kannan Navaneetham

4 Nov 2019

PONE-D-19-26324

The Influence of Health Facility-Level Access Measures on Modern Contraceptive Use in Kinshasa, DRC.

PLOS ONE

Dear Dr. Babazadeh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript was reviewed by two reviewers and their comments are appended below. Both reviewers have raised number of issues. I am sure that the reviewers comments would be very helpful  to revise your manuscript. 

We would appreciate receiving your revised manuscript by Dec 19 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kannan Navaneetham

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In ethics statement in the manuscript and in the online submission form, please provide additional information about the database used in your retrospective study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have their data used in research, please include this information.

3. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately.  These will be automatically included in the reviewers’ PDF.

4. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author.

5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

6. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper linked PMA household data and health facility data to assess the association between women’s contraceptive use and different types of access measured at the EA level, as well as other community-level factors aggregated from individual data. The findings could have important implications for family planning programs in Kinshasa, DRC.

Hope the following comments could help strengthen the paper:

Background:

a) Line #51: the statement “the spatial data from the SPA and DHS have been randomly displaced” is not correct. Geolocations of DHS clusters are displaced but not those of health facilities in SPA surveys. The DHS Program released GPS data collected in SPA without displacement.

b) Line #56: I would not say “the SPA and DHS sampling strategy make it impossible to link at the EA level”. Actually, it is possible to link them at the EA level when the SPA survey is a facility census. Please refer to this report for more detail (https://www.dhsprogram.com/publications/publication-SAR10-Spatial-Analysis-Reports.cfm)

c) Line #58: I don’t think this recommendation was made in the reference #9. Please double check.

d) Study setting: it would be helpful to include some information on contraceptive method mix in Kinshasa. Do more women use LARCs? This may help interpret the findings on the association that having more facilities with LARCs increases the likelihood of contraceptive use.

Methods:

Conceptual framework: this paragraph reads more like a description of different types of access (i.e. their definitions) rather than a conceptual framework. A conceptual framework would demonstrate/discuss the pathway by which variables, alone or in combination, are associated with the outcome of interest. Also it would be helpful to map the SDP-level variables and other community-level variables introduced later to these different “access” categories.

Data:

a) The sample design of the 4 rounds was independent? Or the same EAs were followed over the 4 rounds? This is not clear.

b) It would be helpful to provide some information on the total number of SDPs in EAs from which the SDP sample were selected. Is it possible that same facilities, such as tertiary hospitals are shared by multiple EAs? If this is the case, how did you deal with this in the analysis?

Key independent variables:

a) SDP variables---I have concerns about the SDP variables constructed at the EA level by counting the total number of SDPs. These include the total number of SDPs that off FP methods, total number of SDPs with more than 3 methods, total number of SDPs with more than 5 methods in stock, and several others. These SDPs were a sample of all SDPs that serve the EA. The total count may not represent the service environment unless you count among all SDPs that serve the EA. Plus you have a max value of 6 for all these indicators, right? Because the sample size of SDPs would not exceed 6 in each EA. Instead of counting, for example the total number of SDPs that offer at least 3 FP methods, a proportion measurement, i.e. proportion of SDPs with at least 3 methods might be a better measurement.

Moreover, in the analysis, do you treat these variables as continuous variable? I guess their possible values would be 0, 1 ,2 ,3 ,4 ,5 ,6? They are not continuous.

b) Community-level variables constructed with individual data --- the decision-making variable is not clear. Decision making for what?

Analysis

a) I assumed you pooled data from 4 rounds for the multivariate analysis. Please make this clear in the description

b) I am concerned about putting all the SDP variables in the same model. Did you check the correlation among them? Some may be highly correlated for example, number of facilities with 3 methods and number of facilities with 5 methods. Others could be highly correlated too. I would double check. I wonder if this is the reason for the lack of significance of many SDP variables.

c) Line #239. It should be noted as formula (3)

d) Line #241: It should not be noted as formula (3)

e) Was the complex survey design accounted for in the analysis? The paper did not mention this.

Results

a) Table 2: what is LAPM? This term appears in several places. Please correct/clarify.

b) Line #343-353: where are the results described in this paragraph?

c) Table 4: I did not see the results on the interaction terms. The authors said something about such results in Line #435. But it is not clear which EA-level variables affect contraceptive use differently in the four rounds.

d) Line 387: the association between contraceptive use and number of facilities with water and electricity was negative not positive (OR<1).

e) The authors often use “x% more likely” in the interpretation of odds ratios. This is not correct. These are odds ratios not probabilities. It should be interpreted as something like this: the odds of using contraception is x% more/higher for group A compared to Group B.

f) I did not see where in the results showed the answers to Research Question 2) and 3). To answer these questions, the authors need to assess the additional variation explained by adding another group of variables, for example, from model 2 to model 3, how much (e.g. %) additional variation is explained by adding other community-level variables.

Discussion

a) Line 473: some references seem to be missing here.

b) The authors may want to discuss a few surprising findings from the multivariate analysis: these include: the negative association between contraceptive use and number of facilities with water and electricity in models 2, 3, and 4, negative association between contraceptive use and number of SDPs that insert implant in model 4.

Reviewer #2: I would suggest that the authors frame the introduction and the paper in the context of the Democratic Republic of Congo (DRC) as opposed to what the world as a whole is struggling with. The text in the paragraph on the study setting (i.e., Line 89 - Line 106) could be used to introduce the problem because it is specific to DRC. The authors could then introduce the influence of the Sustainable Development Goals (SDGs) as they have bearing on the way a country like the DRC shapes its health policy. Then the authors could launch into a discussion of how challenging it is to measure or conceptualize access as they did in what is now the third paragraph of the introduction (i.e., Line 42 - Line 58). That lays the groundwork for a statement of objectives and manuscript aims.

The authors state their study aims as bullets (Line 69 - Line 75). I would recommend they weave those statements into the narrative as opposed to stating them separately.

I recommend the authors define their acronyms throughout the paper. Their manuscript makes use of several acronyms and it can make for confusing reading when the meaning of certain acronyms is not clear. For example, Line 56 they methionine EA-Level long before they define it as Enumeration Area in the method section.

The authors should not forget to provide units for measures of certain demographic characteristics. For example, they state the fertility rate as 6.3 (Line 91). Perhaps authors could add births per woman as the unit the first time they report TFR.

Outlining a conceptual framework is most helpful. However, reading through what the authors set out in the methods, I am uncertain as to whether it is a single comprehensive framework or if the authors are cobbling together several constructs from different studies (I am not deeply familiar with Choi et al., 2016). If it is a single comprehensive framework, then the authors should consider describing how the various access constructs are related to each other, or not. And if these are constructs coming together from several studies, then it may be useful for the authors to characterize this properly. For example, in one study from a specific setting, access to mCPR was characterized as Administrative, while in other contexts it is characterized as Psychological access, and so on.

In Line 154, the authors describe the different types of service delivery points (SDPs). They conclude the list by writing, “and others”. It is a bit of a vague characterization. I recommend the authors revisit it.

The methods section the authors describe the explanatory variables, grouping them as availability of mCPRs, contextual factors, and individual-level factors. Within these three groups, I would suggest that they also highlight where these variables fit in the context of the framework, as they summarize in Table A1 of the appendix. By the way, it may be helpful to include that table in the manuscript as opposed to relegating it to the appendix. The table is a nice summary of the variables and is a lot clearer than the textual description provided in the manuscript.

I suggest that the authors move the content of Lines 226 - 228, to the results section. They are a description of the setting derived from analysis of the data similar to their report of individual-level characteristics or the levels of family planning service availability. In reporting the prevalence of contraceptive use by enumeration area (EA), I recommend the authors report the mean prevalence rate and perhaps the range, for each of the rounds of PMA2020. As opposed to just stating that rates ranged from 8% in some to 58% in others.

In Line 275, the authors should consider providing a full citation of STATA (and make sure it is reflected in the bibliography).

For Table 3, I would suggest that the authors show p-values as a footnote like they did for Table 4, as opposed to noting the specified value in the table.

In Table 3, two variables are listed under Mean Age as Non-user and User. Does this mean non-user of modern contraceptives and users of modern contraceptives? It is a bit unclear from the table.

None of the results make mention of household wealth index or mean wealth index at each EA, but the authors mention them as explanatory variables in the methods section (i.e., Line 199 and Line 194 respectively). If those variables are excluded from the analysis, then the authors may want to explain why or leave them out of the methods section altogether.

In the results section, under multivariate multilevel analysis, the authors repeatedly describe their findings as correlations (i.e., the correlation between mCPR and the explanatory variables). Regression is not correlation and I believe the appropriate term used is "association”. The authors may want to check their language here.

I would suggest that the authors shorten their results sections. Much of the points of interest described in text form are summarized neatly in the Tables, particularly Tables 3 and 4. Rather than report on each statistically significant finding, I suggest the authors pick one or two they wish to highlight and use those to frame the arguments they make in the introduction, and those points that are worth revisiting in the discussion.

An issue worth some discussion is whether the forms of access as defined in the study can be ranked (or even whether they should be). For example, does psychological access carry greater weight than service quality of cognitive ability? A ranking of these constructs within the framework of access may offer some insight into additional lines of investigation when considering this issue of access.

I think the discussion section could benefit from an examination of the results mean for the FP2020 Initiative. The authors make note of which associations were statistically significant. But what is the import of such findings? What is the practical significance of demonstrating that in the DRC, mCPR use increases with parity? What does such a finding mean for what can be done to help the country achieve its goal of lowering the fertility rate?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comment_PONE-D-19-26324.docx

PLoS One. 2020 Jul 23;15(7):e0236018. doi: 10.1371/journal.pone.0236018.r002

Author response to Decision Letter 0


16 Apr 2020

We want to thank the editor and both of the reviewers for reviewing our manuscript. Your review adds a tremendous value to our manuscript. The following is our response to the reviewers:

Reviewer #1:

Reviewer #1: The paper linked PMA household data and health facility data to assess the association between women's contraceptive use and different types of access measured at the EA level, as well as other community-level factors aggregated from individual data. The findings could have important implications for family planning programs in Kinshasa, DRC.

Hope the following comments could help strengthen the paper:

Background:

a) Line #51: the statement "the spatial data from the SPA and DHS have been randomly displaced" is not correct. Geolocations of DHS clusters are displaced but not those of health facilities in SPA surveys. The DHS Program released GPS data collected in SPA without displacement.

- The sentence is revised to: "One drawback is the fact that the spatial data from the DHS have been randomly displaced as a confidentiality measure and few SPA surveys have a GPS coordinate data component"

b) Line #56: I would not say "the SPA and DHS sampling strategy make it impossible to link at the EA level". Actually, it is possible to link them at the EA level when the SPA survey is a facility census. Please refer to this report for more detail (https://www.dhsprogram.com/publications/publication-SAR10-Spatial-Analysis-Reports.cfm)

- We changed the sentence to be more accurate. The census sampling may reduce the bias, however not all SPA surveys follow the census sampling strategy.

- The sentences read: "The SPA and DHS sampling strategy make it difficult to link population and facilities at the EA level. To be able to make this happen, the SPA would need to be conducted in the same EAs as the DHS survey and a census sampling of facilities."

c) Line #58: I don't think this recommendation was made in the reference #9. Please double check.

- Wang and colleagues have mentioned this under the section 1.3: "Constraints in Linking Data from Facilities Surveys and Data from Population-Based Surveys"

d) Study setting: it would be helpful to include some information on contraceptive method mix in Kinshasa. Do more women use LARCs? This may help interpret the findings on the association that having more facilities with LARCs increases the likelihood of contraceptive use.

We included the following sentence and related citation: "The method mix among women using modern contraceptives in Kinshasa shows that 55% used Long-Acting Reversible Contraceptive (LARC) methods (injectables, implant, IUD), 43% used other short-acting modern methods, and less than two percent used male or female sterilization [31]"

https://www.pma2020.org/sites/default/files/PMA2018-Kinshasa-R7-FP-Brief-20190201_EN.pdf

Methods:

Conceptual framework: this paragraph reads more like a description of different types of access (i.e. their definitions) rather than a conceptual framework. A conceptual framework would demonstrate/discuss the pathway by which variables, alone or in combination, are associated with the outcome of interest. Also it would be helpful to map the SDP-level variables and other community-level variables introduced later to these different "access" categories.

We decided to add the previously omitted diagram of our conceptual framework based on your recommendation. We believe that the framework would contribute to the method section if accompanied with the table of variables and their relative access measure. Figure 1 shows the conceptual framework of the current study.

Data:

a) The sample design of the 4 rounds was independent? Or the same EAs were followed over the 4 rounds? This is not clear.

The sampling design has been consistent throughout 4 rounds. We have clarified the this fact in the following added sentence:

". The surveys were conducted in the same 58 enumeration areas (EA) in four annual and semi-annual rounds (rounds 2-5) between 2014 and 2016 (rounds three and four were conducted in 2015). Therefore, the sample is consisting of a panel of 58 EA selected in four rounds of data collection."

b) It would be helpful to provide some information on the total number of SDPs in EAs from which the SDP sample were selected. Is it possible that same facilities, such as tertiary hospitals are shared by multiple EAs? If this is the case, how did you deal with this in the analysis?

The SDPs were selected from a list of SDPs that was provided by the DRC Ministry of Health. Each SDP type was selected in a selected EA if it served that EA. For example, there is only one tertiary hospital in Kinshasa. Thus, this hospital has been selected in all rounds of the data collection as one SDP that serves all EA. Consecuently, where there is always three selected private SDPs in each EA, in some EAs we have selevted less than three public SDPs. We have added the following sentences to clarify:

"Following this sampling approach, some SDPs have been selected in our sample more than once. However, since they are a small fraction of all SDPs (less than 8% of all SDPs), and deleting them from the analysis did not make any significant changes, we decided to keep the SDPs that where selected in multiple rounds. "

Key independent variables:

a) SDP variables---I have concerns about the SDP variables constructed at the EA level by counting the total number of SDPs. These include the total number of SDPs that off FP methods, total number of SDPs with more than 3 methods, total number of SDPs with more than 5 methods in stock, and several others. These SDPs were a sample of all SDPs that serve the EA. The total count may not represent the service environment unless you count among all SDPs that serve the EA. Plus you have a max value of 6 for all these indicators, right? Because the sample size of SDPs would not exceed 6 in each EA. Instead of counting, for example the total number of SDPs that offer at least 3 FP methods, a proportion measurement, i.e. proportion of SDPs with at least 3 methods might be a better measurement.

Moreover, in the analysis, do you treat these variables as continuous variable? I guess their possible values would be 0, 1 ,2 ,3 ,4 ,5 ,6? They are not continuous.

We appreciate your valid points about the constructed EA variable. However, due to some constraints in the sampling method (not knowing the real denominator for the SDPs and few number of SDPs with certain charecteristics) and for practical reasons, we decided to use the total number versus the proportion of the SDPs for some of the SDP characteristics. For three of the SDP variables (number of days of service, number of methods provided, and number of methods stocked out) we used the average values for all SDPs within an enumeration area. Furthermore, since the number of SDPs within each EA is a limited small number (here is 6), the percentage of SDPs produce a less accuaret measure and

b) Community-level variables constructed with individual data --- the decision-making variable is not clear. Decision making for what?

This variable is constructed from the question "Who made the final decision for using modern contraceptive method on current or previous FP use?". We have relocated the table of variables from the appendix to the methods section to clarify the variables used in the analysis.

Analysis

a) I assumed you pooled data from 4 rounds for the multivariate analysis. Please make this clear in the description.

We clarified this fact. The first sentence in the analysis section now reads:" Descriptive analysis is performed for both individual and EA-level variables on a pooled cross-section data from the four rounds of PMA2020 in Kinshasa. We perform the analysis with tabulation of background characteristics for our study population in each round of data."

b) I am concerned about putting all the SDP variables in the same model. Did you check the correlation among them? Some may be highly correlated for example, number of facilities with 3 methods and number of facilities with 5 methods. Others could be highly correlated too. I would double check. I wonder if this is the reason for the lack of significance of many SDP variables.

We appreciate your valid point. However, only three of the SDP-variables were slightly correlated that excluding them did not change any significant results. Therefore we decided to keep them in the model since most of them are among important monitoring indicators.

c) Line #239. It should be noted as formula (3)

Thanks for Catching this error. It is corrected now.

(1) Yij = β0j + β1jXij + rij

Level 2 (EA level)

(2) β0j = γ00 + γ01Zj + u0j

(3) β1j = γ10

Substitution of (2 ) and ( 3 ) in ( 1 )

Yij = γ00 + γ10Xij + γ01Zj + rij + u0j

d) Line #241: It should not be noted as formula (3)

Corrected. See above (c).

e) Was the complex survey design accounted for in the analysis? The paper did not mention this.

We added the following sentence: "The analysis was weighted to correct for the complex survey design used by PMA2020. "

Results:

a) Table 2: what is LAPM? This term appears in several places. Please correct/clarify.

The footnote is added to the table to clarify.

b) Line #343-353: where are the results described in this paragraph?

This paragraph is describing the results from the bivariate analysis of modern contraceptive use and SDP variables. However, we have decided to omit the table from the final draft to save some space. Since none of the SDP variables were significantly associated with modern contraceptive use in all rounds, we are going to delete this paragraph.

c) Table 4: I did not see the results on the interaction terms. The authors said something about such results in Line #435. But it is not clear which EA-level variables affect contraceptive use differently in the four rounds.

The interaction of the time variable (round) and community level variables were used to control the changes in those variables over time. We have not shown the coefficients for the interaction terms to save some space in the table. We added a note for this problem to clarify.

d) Line 387: the association between contraceptive use and number of facilities with water and electricity was negative not positive (OR<1).

We deleted the sentence.

e) The authors often use "x% more likely" in the interpretation of odds ratios. This is not correct. These are odds ratios not probabilities. It should be interpreted as something like this: the odds of using contraception is x% more/higher for group A compared to Group B.

We corrected this issue throughout the text.

f) I did not see where in the results showed the answers to Research Question 2) and 3). To answer these questions, the authors need to assess the additional variation explained by adding another group of variables, for example, from model 2 to model 3, how much (e.g. %) additional variation is explained by adding other community-level variables.

We have showed this fact with reporting the likelihood ratio test (LR) to statistically test the goodness of fit of each model against the previous. We also added the following sentences in the text to clarify the results. However, in logistic regression (contrary to OLS regression), creating a statistic that provides the same information as R2 is difficult. Our result shows that in each model, we have a significant likelihood ratio value which means that adding the new set of variables would still benefit the goodness of fit in our model.

Discussion

a) Line 473: some references seem to be missing here.

We added the reference.

Reviewer #2:

1. I would suggest that the authors frame the introduction and the paper in the context of the Democratic Republic of Congo (DRC) as opposed to what the world as a whole is struggling with. The text in the paragraph on the study setting (i.e., Line 89 - Line 106) could be used to introduce the problem because it is specific to DRC. The authors could then introduce the influence of the Sustainable Development Goals (SDGs) as they have bearing on the way a country like the DRC shapes its health policy. Then the authors could launch into a discussion of how challenging it is to measure or conceptualize access as they did in what is now the third paragraph of the introduction (i.e., Line 42 - Line 58). That lays the groundwork for a statement of objectives and manuscript aims.

We appreciate your recommendation. We believe this would help the reader to better understand the aim of this study. We have changed the introduction accordingly. We have integrated the "Stduy setting" section in the "Background" according to your recommended outline.

2. The authors state their study aims as bullets (Line 69 - Line 75). I would recommend they weave those statements into the narrative as opposed to stating them separately.

We followed the recommendation. The new pragarph reads: "In this study we aimed to investigate the extent to which EA-level FP supply and services impact the modern contraceptive use among women in reproductive age in Kinshasa, DRC. Also, we aimed to assess if variability in contraceptive use among women in reproductive age in Kinshasa can be explained by differences in EA-level contextual factor variables."

3. I recommend the authors define their acronyms throughout the paper. Their manuscript makes use of several acronyms and it can make for confusing reading when the meaning of certain acronyms is not clear. For example, Line 56 they methionine EA-Level long before they define it as Enumeration Area in the method section.

We appreciate you catching this issue. We tried to spell out each acronym the first time it shows up in the text. We checked the text again to follow our rule.

4. The authors should not forget to provide units for measures of certain demographic characteristics. For example, they state the fertility rate as 6.3 (Line 91). Perhaps authors could add births per woman as the unit the first time they report TFR.

We added units of measures where it was necessary per your recommendation.

5. Outlining a conceptual framework is most helpful. However, reading through what the authors set out in the methods, I am uncertain as to whether it is a single comprehensive framework or if the authors are cobbling together several constructs from different studies (I am not deeply familiar with Choi et al., 2016). If it is a single comprehensive framework, then the authors should consider describing how the various access constructs are related to each other, or not. And if these are constructs coming together from several studies, then it may be useful for the authors to characterize this properly. For example, in one study from a specific setting, access to mCPR was characterized as Administrative, while in other contexts it is characterized as Psychological access, and so on.

The conceptual framework was adopted from the Choi et al. study. Choi et al. synthesized the key access elements for measurement by reviewing three well‐known frameworks. All the elements used in their study were common among the three frameworks (Penchansky and Thomas 1981, Bertrand et al. 1995, and AAAQ proposed by United Nations Committee on Economic, Social, and Cultural Rights in 2000). Choi et al. used the DHS survey to measure access based on their synthesized framework.

We used their synthesized framework to measure the elements of the access using PMA2020 population and facility surveys. Choi et al have discussed the limitations if measuring the elements of access based on solely on source of data (the DHS survey). Similarly, we have mentioned the limitations to our study, although, we used two sources of data (population and facility surveys).

In order to clarify the conceptual framework, we decided to add the previously omitted diagram of our conceptual framework based on your recommendation. We believe that the framework would contribute to the method section if accompanied with the table of variables and their relative access measure.

6. In Line 154, the authors describe the different types of service delivery points (SDPs). They conclude the list by writing, "and others". It is a bit of a vague characterization. I recommend the authors revisit it.

We clarified the sentence by providing an example. The new sentence reads: "Private SDPs included faith-based SDPs, pharmacies, clinics, and other unofficial providers of FP methods (such as kiosks)."

7. The methods section the authors describe the explanatory variables, grouping them as availability of mCPRs, contextual factors, and individual-level factors. Within these three groups, I would suggest that they also highlight where these variables fit in the context of the framework, as they summarize in Table A1 of the appendix. By the way, it may be helpful to include that table in the manuscript as opposed to relegating it to the appendix. The table is a nice summary of the variables and is a lot clearer than the textual description provided in the manuscript.

We appreciate you recommendation. Per your advice, we included the appendix table within the manuscript to clarify the relation of the variable used in the analysis to the conceptual framework.

8. I suggest that the authors move the content of Lines 226 - 228, to the results section. They are a description of the setting derived from analysis of the data similar to their report of individual-level characteristics or the levels of family planning service availability. In reporting the prevalence of contraceptive use by enumeration area (EA), I recommend the authors report the mean prevalence rate and perhaps the range, for each of the rounds of PMA2020. As opposed to just stating that rates ranged from 8% in some to 58% in others.

9. In Line 275, the authors should consider providing a full citation of STATA (and make sure it is reflected in the bibliography).

We added the proper citation.

10. For Table 3, I would suggest that the authors show p-values as a footnote like they did for Table 4, as opposed to noting the specified value in the table.

In Table 3, two variables are listed under Mean Age as Non-user and User. Does this mean non-user of modern contraceptives and users of modern contraceptives? It is a bit unclear from the table.

We changed the categories to "FP user" and "FP nonuser" to be more clear.

11. None of the results make mention of household wealth index or mean wealth index at each EA, but the authors mention them as explanatory variables in the methods section (i.e., Line 199 and Line 194 respectively). If those variables are excluded from the analysis, then the authors may want to explain why or leave them out of the methods section altogether.

We have variables of household wealth at individual level and community level in our final fitted models. However, the wealth variables have no association to modern contraceptive use. In the second paragraph of the discussion section we have stated: "Surprisingly, our findings did not confirm the role of wealth on modern contraceptive use. This finding is in contrast with previous results of studies from other countries [9, 47, 48], but consistent with another study from the DRC[49]."

12. In the results section, under multivariate multilevel analysis, the authors repeatedly describe their findings as correlations (i.e., the correlation between mCPR and the explanatory variables). Regression is not correlation and I believe the appropriate term used is "association". The authors may want to check their language here.

We appreciate your correction. We changed the language throughout the manuscript.

13. I would suggest that the authors shorten their results sections. Much of the points of interest described in text form are summarized neatly in the Tables, particularly Tables 3 and 4. Rather than report on each statistically significant finding, I suggest the authors pick one or two they wish to highlight and use those to frame the arguments they make in the introduction, and those points that are worth revisiting in the discussion.

We appreciate your comment. Per your recommendation we have shortened the results section to cover the most important findings.

14. An issue worth some discussion is whether the forms of access as defined in the study can be ranked (or even whether they should be). For example, does psychological access carry greater weight than service quality of cognitive ability? A ranking of these constructs within the framework of access may offer some insight into additional lines of investigation when considering this issue of access.

Authors appreciate the reviewer mentioning this point. The present study attempted to shed light on the relationship of some of the supply environment access measures rather than provide a conceptual framework. We agree with the reviewer's comment that the ranking of these access constructs is worth investigating. However, this research question is beyond the scope of this study.

15. I think the discussion section could benefit from an examination of the results mean for the FP2020 Initiative. The authors make note of which associations were statistically significant. But what is the import of such findings? What is the practical significance of demonstrating that in the DRC, mCPR use increases with parity? What does such a finding mean for what can be done to help the country achieve its goal of lowering the fertility rate?

We added the following to clarify the discussion we had previously. We added: "Our findings further indicate that the applied elements of access using PMA2020 as the source of data is not necessarily sufficient to monitor FP2020 goal achievement. Whereas, FP2020 monitoring framework consist of a set of a indicators captured by some of these six elements (For example, contraceptive supply stock-out and contraceptive supply availability). Many other sources of data (service statistics, client exit interview, or administrative information) are required to capture all elements of access accurately."

Decision Letter 1

Kannan Navaneetham

6 May 2020

PONE-D-19-26324R1

The Influence of Health Facility-Level Access Measures on Modern Contraceptive Use in Kinshasa, DRC.

PLOS ONE

Dear Dr. Babazadeh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript is sent to the reviewer who reviewed the previous version. The reviewer has suggested some minor issues which needs to be addressed. The reviewer comments is appended below. Moreover, the manuscript needs to be edited by a professional editor. In some places it is not readable that could be improved for the benefit of readers, though the meaning is clear for the authors.  I am sure that the comments by the reviewer would help to improve the quality of the manuscript.

We would appreciate receiving your revised manuscript by Jun 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kannan Navaneetham, PhD

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: As noted in my first review, this is a good manuscript publishing. It touches on an important issue particularly for audiences interested in fertility and family planning in the DRC and that particular subregion of Africa. The authors have implemented the comments I posed during my first review. I have some additional comments and suggestions which may help to further improve the quality of the submitted manuscript, please see below.

Introduction

I think the introduction could be shortened by quite a bit.

Please provide a reference for the DRC policy stated in Line 63 through 66.

Please provide a reference for the mCPR figures reported in Line 71.

In terms of structure, I believe it is best to begin the manuscript from a broad global perspective and then narrow it down to focus on DRC. As written the manuscript begins by talking about the specific goals of the DRC in the context of its African subregion. Then in the third paragraph (Line 75 through 84) the authors suddenly move back to the global objectives regarding fertility and family planning. Much of that information in that paragraph could also be condensed to a few lines. In the interest of keeping the introduction a bit shorter, I think the authors can reference those global mobilization efforts and mention that they have influenced the DRC’s specific policies, as opposed to devoting one paragraph to them.

It is best to provide the full name of the meeting as opposed to simply describing it as the London Summit (Line 76)

I believe the authors can also shorten the two paragraphs that situate the idea of access (Line 86 - 91) and measuring access (Line 93 through 109). Perhaps those two paragraphs could be consolidated as well. For example, in the paragraph that discusses measuring access and the tools available; I feel the conversation abut the limitations of DHS and SPA data can be saved for the discussion. Simply focus the paragraph on the advantage of using

The last paragraph (Line 128 - 138) is not necessary, especially after the manuscript’s broad objectives and aims have stated previously.

Methods

It is a good idea to have a couple of sentences to explain the choices of the constructs in the methodological framework perhaps tying it back to the idea of an inadequate definition of access and the difficulties associated with measuring access. I am asking for some justification in choosing those six constructs (Line 144). Also, the placement of that paragraph seems odd, given that it has no connection to the measurements section of the paper which is what the conceptual framework serves.

I am not sure the data subsection should be used for contrasting DHS and SPA surveys with the survey design of PMA2020. Really this subsection should focus on describing PMA2020 and its design. It may also be relevant to state or highlight the partnership that led to the PMA2020 surveys.

Results

The grammar is a bit muddled in the initial reports of findings. The authors report certain figures as if they were looking at cross-sectional data as opposed to multiple waves of data. For example, Line 333, the authors mention that “Women had 1.7-1.8 live children on average at the time of the interview”. When I think they mean to say that across the four waves, average live child ranged from 1.7 to 1.8. Be clear that those statistics reported range over the different rounds of PMA2020.

The heading of Table 02 should indicate that it contains bivariate analysis results.

Pick between the adjectives, “highly” or “hugely” in Line 344.

The authors need to think a bit about what figures are reported versus those that are not for example. In Lines 357 and 358 they report the mean number of FP methods offered during each wave. They choose to report it as a range. However, given the mean methods available peaks in round 3 and then declines it may be better to just note which survey round had the highest mean of modern methods, as a precursor to a discussion.

Please carefully check the use of acronyms, as LAPM is sometimes written as LAMP (see Lines 360 to 362 as an example).

In reporting figures, there is no consistency in the use of decimal places. For example, Table 03 uses one decimal place for all the figures. While Table 04 has some p-values reported with four decimal places. Do check with the journal, typically p-values less than 0.001 are simply reported as <0.001. Review the journal's guidelines and be consistent in the reporting of significant figures.

Discussion

The first few sentences in the paragraph beginning on Line 536 and going through Line 539 are confusing. Why not just state that enumeration areas do not equate to actual communities and that in reality, communities cross the demarcations produced in establishing EAs.

I think this section of the manuscript is where you bring up the shortcomings of DHS data which is what has typically been used for this type of analysis and how by using PMA2020 data you were able to avoid those shortcomings. As opposed to discussing those issues extensively within the introduction, as is currently the case.

Conclusion

Please review the paragraph beginning with Line 592. It is not entirely clear what is being proposed as a policy intervention to affect the supply chain of LAPMs.

Additionally, the idea of FP supply is introduced rather late in the manuscript. Is this something the authors came across when researching the extant literature? Alternatively, did they find instances of other countries on the region/subcontinent struggling with supply as a policy issue? It may be something to bring up in the introduction then.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Jul 23;15(7):e0236018. doi: 10.1371/journal.pone.0236018.r004

Author response to Decision Letter 1


25 Jun 2020

We appreciate the reviewer’s comments to strengthen the presentation of this study. We have responded to the comments and have made the changes as follows:

Introduction

1- I think the introduction could be shortened by quite a bit.

- We have revised the introduction to shorten it.

2- Please provide a reference for the DRC policy stated in Line 63 through 66.

- Thank you for noticing. We added the citation.

3- Please provide a reference for the mCPR figures reported in Line 71.

- We added the citation.

4- In terms of structure, I believe it is best to begin the manuscript from a broad global perspective and then narrow it down to focus on DRC. As written the manuscript begins by talking about the specific goals of the DRC in the context of its African subregion. Then in the third paragraph (Line 75 through 84) the authors suddenly move back to the global objectives regarding fertility and family planning. Much of that information in that paragraph could also be condensed to a few lines. In the interest of keeping the introduction a bit shorter, I think the authors can reference those global mobilization efforts and mention that they have influenced the DRC’s specific policies, as opposed to devoting one paragraph to them.

- We revised the introduction to follow the recommended order.

5- It is best to provide the full name of the meeting as opposed to simply describing it as the London Summit (Line 76)

- We edited the name. However, we decided to delete that sentence to shorten the introduction.

6- I believe the authors can also shorten the two paragraphs that situate the idea of access (Line 86 - 91) and measuring access (Line 93 through 109). Perhaps those two paragraphs could be consolidated as well. For example, in the paragraph that discusses measuring access and the tools available;

- We have revised the mentioned paragraph to be more concise.

7- I feel the conversation abut the limitations of DHS and SPA data can be saved for the discussion. Simply focus the paragraph on the advantage of using

- We believe that the difference between the previous instruments and surveys to measure access and PMA2020 is important. However, in our discussion we tried to emphasize the significance of the results of current study in the context of the DRC rather than discussing the survey. In addition, Choi et al. have published an article using DHS to measure access and have discussed the shortcomings of the instrument.

8- The last paragraph (Line 128 - 138) is not necessary, especially after the manuscript’s broad objectives and aims have stated previously.

- We deleted the paragraph.

Methods

9- It is a good idea to have a couple of sentences to explain the choices of the constructs in the methodological framework perhaps tying it back to the idea of an inadequate definition of access and the difficulties associated with measuring access. I am asking for some justification in choosing those six constructs (Line 144). Also, the placement of that paragraph seems odd, given that it has no connection to the measurements section of the paper which is what the conceptual framework serves.

- We have adopted the framework from previous relevant publications on frameworks of access to family planning service (Bertran et al. 1994 and Choi et al. 2016)

10- I am not sure the data subsection should be used for contrasting DHS and SPA surveys with the survey design of PMA2020. Really this subsection should focus on describing PMA2020 and its design. It may also be relevant to state or highlight the partnership that led to the PMA2020 surveys.

- We edited the paragraph to follow your recommendation.

Results

11- The grammar is a bit muddled in the initial reports of findings. The authors report certain figures as if they were looking at cross-sectional data as opposed to multiple waves of data. For example, Line 333, the authors mention that “Women had 1.7-1.8 live children on average at the time of the interview”. When I think they mean to say that across the four waves, average live child ranged from 1.7 to 1.8. Be clear that those statistics reported range over the different rounds of PMA2020.

- We revised the result section to clarify.

12- The heading of Table 02 should indicate that it contains bivariate analysis results.

- Table 2 shows the results based on Analysis of Variances and Chi Square test between different round. We clarified this in the text and the explanation under the table.

13- Pick between the adjectives, “highly” or “hugely” in Line 344.

- We appreciate the reviewer picking this typo.

-

14- The authors need to think a bit about what figures are reported versus those that are not for example. In Lines 357 and 358 they report the mean number of FP methods offered during each wave. They choose to report it as a range. However, given the mean methods available peaks in round 3 and then declines it may be better to just note which survey round had the highest mean of modern methods, as a precursor to a discussion.

- We appreciate your recommendation. We revised the result section to follow your recommendation.

-

15- Please carefully check the use of acronyms, as LAPM is sometimes written as LAMP (see Lines 360 to 362 as an example).

- We appreciate you noticing this typo. We corrected the error across the text.

16- In reporting figures, there is no consistency in the use of decimal places. For example, Table 03 uses one decimal place for all the figures. While Table 04 has some p-values reported with four decimal places. Do check with the journal, typically p-values less than 0.001 are simply reported as <0.001. Review the journal's guidelines and be consistent in the reporting of significant figures

- We appreciate the reviewer for catching this problem. We fixed the inconsistencies in Table 3.

Discussion

17- The first few sentences in the paragraph beginning on Line 536 and going through Line 539 are confusing. Why not just state that enumeration areas do not equate to actual communities and that in reality, communities cross the demarcations produced in establishing EAs.

- We followed the reviewer’s directions to clarify the mentioned limitation of this study.

18- I think this section of the manuscript is where you bring up the shortcomings of DHS data which is what has typically been used for this type of analysis and how by using PMA2020 data you were able to avoid those shortcomings. As opposed to discussing those issues extensively within the introduction, as is currently the case.

- We appreciate the reviewer’s recommendation. We agree on this point that the difference of DHS and PMA2020 methodology and instruments are important when we measure access using these resources. However, in the current study aimed to practically usePMA2020 results in the context of the DRC rather than discussing the survey. In addition, Choi et al. have published an article using DHS to measure access and have discussed the shortcomings of the instrument.

Conclusion

19- Please review the paragraph beginning with Line 592. It is not entirely clear what is being proposed as a policy intervention to affect the supply chain of LAPMs.

- We revised the conclusion to clarify.

20- Additionally, the idea of FP supply is introduced rather late in the manuscript. Is this something the authors came across when researching the extant literature? Alternatively, did they find instances of other countries on the region/subcontinent struggling with supply as a policy issue? It may be something to bring up in the introduction then.

-We revised the conclusion to clarify.

Attachment

Submitted filename: Response to the reviewer.docx

Decision Letter 2

Kannan Navaneetham

29 Jun 2020

The influence of health facility-level access measures on modern contraceptive use in Kinshasa, DRC

PONE-D-19-26324R2

Dear Dr. Babazadeh,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kannan Navaneetham, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Kannan Navaneetham

9 Jul 2020

PONE-D-19-26324R2

The influence of health facility-level access measures on modern contraceptive use in Kinshasa, DRC

Dear Dr. Babazadeh:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Kannan Navaneetham

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Comment_PONE-D-19-26324.docx

    Attachment

    Submitted filename: Response to the reviewer.docx

    Data Availability Statement

    Data can be found on PMA2020 website and is available upon request at the IPUMS PMA repository at: https://pma.ipums.org/pma/index.shtml IPUMS PMA is a publicly available data that harmonizes the international family planning survey series Performance Monitoring for Action, or PMA (formerly known as Performance Monitoring and Accountability 2020 or PMA2020)


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES